$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Polymer conjugates of therapeutic peptides 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-038/00
  • A61K-047/48
  • A61K-038/10
  • A61K-038/16
  • A61K-038/28
출원번호 US-0664582 (2015-03-20)
등록번호 US-9682153 (2017-06-20)
발명자 / 주소
  • Bossard, Mary J.
  • Roczniak, Steven O.
  • Zappe, Harold
  • Wang, Yujun
  • Zhang, Ping
  • Sheng, Dawei
  • Jude-Fishburn, C. Simone
  • Minamitani, Elizabeth Louise
  • Liu, Xiaofeng
  • Moskowitz, Haim
  • Fry, Dennis G.
  • Ali, Cherie F.
  • Brew, Christine Taylor
출원인 / 주소
  • Nektar Therapeutics
인용정보 피인용 횟수 : 0  인용 특허 : 141

초록

The invention provides peptides that are chemically modified by covalent attachment of a water-soluble oligomer. A conjugate of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from the characteristics of the peptide not attach

대표청구항

1. A conjugate having the structure: where: mPEG is CH3O—(CH2CH2O)nCH2CH2—;n is an integer from 10 to 1800;R1 is H or lower alkyl;R2 is H or lower alkyl;X1 and X2 are each independently —NH—C(O)—CH2—O—, —NH—C(O)—(CH2)q—O—, —NH—C(O)—(CH2)q—CO—NH—, —NH—C(O)—(CH2)q—, or —C(O)—NH—;q is 2, 3, 4, or 5;˜N

이 특허에 인용된 특허 (141)

  1. Zalipsky Shmuel (Edison NJ), Active carbonates of polyalkylene oxides for modification of polypeptides.
  2. Baker Jeffrey C. ; Hanquier Jose M., Acylated Insulin Analogs.
  3. Frost Richard C. (Fort Worth TX) Gomez Eduardo W. (Fort Worth TX) McAnally Robert W. (Fort Worth TX), Airfoil variable cambering device and method.
  4. Kahn Michael, Alpha-helix mimetics and methods relating thereto.
  5. Kahn Michael, Alpha-helix mimetics and methods relating thereto.
  6. Kahn Michael (Bellevue WA), Alpha-helix mimetics and methods relating thereto.
  7. Kahn Michael ; Kim Hwa-Ok ; Urban Jan, Alpha-helix mimetics and methods relating thereto.
  8. Whitman Russell B. (Dix Hills NY) Wohl Robert (South Setauket NY) Duff Ronald G. (East Moriches NY), Angiogenic peptides.
  9. Matsumoto,Hirokazu; Horikoshi,Yasuko; Kitada,Chieko; Ohtaki,Tetsuya, Anti-metasin antibodies and their methods of use.
  10. Smith Adrian E. ; Burr John D. ; Etter Jeffrey W. ; Axford George S. ; Anthony Jack M., Apparatus and methods for dispersing dry powder medicaments.
  11. Kominek Jiri (Vienna ATX) Zehentgruber Otto (Vienna ATX) Salzbrunn Wolfgang (Wiener Neustadt ATX), Arrangement for growing permanent forms of microorganisms.
  12. Bentley,Michael David; Zhao,Xuan; Shen,Xiaoming; Battle, III,William Dudley, Branched polymers and their conjugates.
  13. Young Niels Owen (Boise ID), Capillary feed boiler.
  14. Young,Thomas M.; Richardson,Mark; Lerner,Robert A.; Rabin,Barry H., Capillary pumps for vaporization of liquids.
  15. Blood, Christine H.; Shadiack, Annette M.; Bernstein, Joanna K.; Herbert, Guy H., Compositions and methods for treatment of sexual dysfunction.
  16. Blood, Christine H.; Shadiack, Annette M.; Bernstein, Joanna K.; Herbert, Guy H., Compositions and methods for treatment of sexual dysfunction.
  17. Patton, John S.; Kuo, Mei-Chang; Harris, J. Milton; Leach, Chester; Perkins, Kimberly; Bueche, Blaine, Compositions of chemically modified insulin.
  18. Kahn Michael (Chicago IL), Confomationally restricted mimetics of beta turns and beta bulges and peptides containing the same.
  19. Kahn Michael (Chicago IL), Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same.
  20. Kahn Michael (Chicago IL), Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same.
  21. Kahn Michael (Chicago IL), Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same.
  22. Kahn Michael (950 W. Berwyn St. ; Unit 12 Chicago IL 60640), Conformationally restricted mimetics of gamma turns and peptides containing the same.
  23. Kahn Michael (Chicago IL), Conformationally restricted mimetics of gamma turns and peptides containing the same.
  24. Bentley, Michael D.; Culbertson, Sean; McManus, Samuel P., Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates.
  25. Ekwuribe Nnochiri N. (Southfield MI), Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and m.
  26. Ekwuribe Nnochiri N. (Southfield MI), Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and m.
  27. Dvorsky James E. ; Chongsiriwatana Songsdhit, Directionally controlled EHD aerosol sprayer.
  28. Wetterlin Kjell I. L. (S. Sandby SEX), Dosage device.
  29. Wetterlin Kjell I. L. (S Sandby SEX), Dosage inhalator.
  30. Ekwuribe,Nnochiri N.; Ramaswamy,Muthukumar; Rajagopalan,Jayanthi, Drug-oligomer conjugates with polyethylene glycol components.
  31. Kuo, Mei-Chang; Lechuga-Ballesteros, David, Dry powder compositions having improved dispersivity.
  32. Burr John D. ; Smith Adrian E. ; Hall Randy K. ; Snyder Herman ; Schuler Carlos ; Axford George S. ; Ray Charles, Dry powder dispersing apparatus and methods for their use.
  33. Mulhauser Paul (New York NY) Karg Jeffrey (Waldwick NY) Foxen Thomas (Brooklyn NY) Brooks Christopher J. (Glen Head NY), Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same.
  34. Lloyd Lester J. (Orinda CA) Lloyd Peter M. (Oakland CA) Rubsamen Reid M. (Berkley CA) Schuster Jeffrey A. (Berkley CA), Dynamic particle size control for aerosolized drug delivery.
  35. Kreek Mary Jeanne, Dynorphin a suppression of natural killer cell activity.
  36. Dolence Eric Kurt (Salt Lake City UT) Hu Chen-Ze (Salt Lake City UT) Tsang Ray (North Salt Lake UT) Sanders Clifton G. (Salt Lake City UT) Osaki Shigemasa (Sandy UT), Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces.
  37. Jamas Spiros (Boston MA) Rha ChoKyun (Boston MA) Sinskey Anthony J. (Boston MA), Glucan composition and process for preparation thereof.
  38. Jamas Spiros (Boston MA) Rha ChoKyun (Boston MA) Sinskey Anthony J. (Boston MA), Glucan composition and process for preparation thereof.
  39. Jamas Spiros (Boston MA) Rha ChoKyun (Boston MA) Sinskey Anthony J. (Boston MA), Glucan compositions and process for preparation thereof.
  40. Jamas Spiros (Boston MA) Ostroff Gary R. (Worcester MA) Easson ; Jr. D. Davidson (Shrewsbury MA), Glucan drug delivery system and adjuvant.
  41. Jamas Spiros ; Ostroff Gary R. ; Easson ; Jr. D. Davidson, Glucan drug delivery system and adjuvant.
  42. Sommermeyer Klaus,DEX ; Eichner Wolfram,DEX, Haemoglobin-hydroxyethyl starch conjugates as oxygen carriers.
  43. Draber Wilfried (Wuppertal DEX) Santel Hans-Joachim (Leverkusen DEX) Schmidt Robert R. (Bergisch Gladbach DEX) Strang Robert H. (Duesseldorf DEX), Herbicidal imidazo-pyrrolo-pyridine derivatives.
  44. Michael David Bentley ; J. Milton Harris ; Antoni Kozlowski, Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation.
  45. Young, Thomas M.; Richardson, Mark; Lerner, Robert A., High fluid flow and pressure in a capillary pump for vaporization of liquid.
  46. Greenwald Richard B. ; Pendri Annapurna, High molecular weight polymer-based prodrugs.
  47. Greenwald Richard B. ; Pendri Annapurna, High molecular weight polymer-based prodrugs.
  48. Michael David Bentley ; Xuan Zhao, Hydrolytically degradable carbamate derivatives of poly (ethylene glycol).
  49. Bentley, Michael David; Zhao, Xuan, Hydrolytically degradable carbamate derivatives of poly(ethylene glycol).
  50. J. Milton Harris ; Michael David Bentley ; Xuan Zhoa ; Xiaoming Shen, Hydrolytically degradable polymers and hydrogels made therefrom.
  51. Hopp, Thomas P., Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity.
  52. McMichael John (Cambridge Springs PA), Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms.
  53. Vinik Aaron I. ; Pittenger Gary L. ; Rafaeloff Ronit ; Rosenberg Lawrence,CAX ; Duguid William P.,CAX, Ingap protein involved in pancreatic islet neogenesis.
  54. Cocozza Salvatore (Milan IT), Inhalers and insufflators having a cutting means.
  55. Wahren, John; Johansson, Bo-Lennart; Jornvall, Hans, Insulin C-peptides.
  56. Smith, Richard D.; Kim, Taeman; Tang, Keqi; Udseth, Harold R., Ionization source utilizing a jet disturber in combination with an ion funnel and method of operation.
  57. Smith, Richard D.; Kim, Taeman; Udseth, Harold R., Ionization source utilizing a multi-capillary inlet and method of operation.
  58. Harris J. Milton, Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for m.
  59. Ivri Yehuda ; Wu Cheng H., Liquid dispensing apparatus and methods.
  60. Ivri Yehuda ; Wu Cheng H., Liquid dispensing apparatus and methods.
  61. Thomas M. Young ; Niels O. Young, Liquid vaporization and pressurization apparatus and methods.
  62. Young Thomas M. ; Young ; deceased Niels O. ; Young ; legal representative by Lucy J., Liquid vaporization and pressurization apparatus and methods.
  63. Fridkin, Matityahu; Shechter, Yoram; Gershonov, Eytan, Long-acting drugs and pharmaceutical compositions comprising them.
  64. Deghenghi Romano,CHX ITX 1264, Lysine containing peptides for treatment of heart disease.
  65. Sharma Somesh D. (Los Altos CA) Clark Brian R. (Redwood City CA) Lerch Bernard L. (Palo Alto CA), MHC class II-peptide conjugates useful in ameliorating autoimmunity.
  66. Purewal Tarlochan S. (Leamington Spa GB2) Greenleaf David J. (Loughborough GB2), Medicinal aerosol formulations.
  67. Purewal Tarlochan S. (Leamington Spa GB2) Greenleaf David J. (Loughborough GB2), Medicinal aerosol formulations.
  68. Fujii, Nobutaka; Doi, Ryuichiro; Oishi, Shinya, Metastin derivatives and their use.
  69. Byron Peter R. (Richmond VA) Blondino Frank E. (Richmond VA), Metered dose inhaler fomulations which include the ozone-friendly propellant HFC 134a and a pharmaceutically acceptable.
  70. Smith Adrian E. ; Burr John D. ; Etter Jeffery W. ; Axford George S. ; Lyons Shirley W. ; Platz Robert M., Method and apparatus for dispersion of dry powder medicaments.
  71. Patton John S. (San Carlos CA) Platz Robert M. (Half Moon Bay CA), Method and device for delivering aerosolized medicaments.
  72. Cipolla David C. (San Francisco CA) Gonda Igor (San Francisco CA), Method for collection of aerosolized proteins by inert filtration.
  73. Polt Robin L., Method for making amino acid glycosides and glycopeptides.
  74. Ellis,David J.; Miljanich,George P.; Shields,David E., Method for reducing pain.
  75. Antoni Kozlowski, Method for the preparation of 1-benzotriazolylcarbonate esters of poly(ethylene glycol).
  76. McMichael John (Delanson NY), Method for treatment of benign prostatic hypertrophy.
  77. Laube, Beth L.; Adams, III, G. Kenneth; Georgopoulos, Angeliki, Method of administering insulin.
  78. Rubsamen Reid M. (Berkeley CA) Lloyd Lester John (Orinda CA), Method of administration of insulin.
  79. Henriksen, Dennis B.; Holst, Jens J., Method of inhibiting bone resorption and/or promoting bone formation using GLP-2 and related compounds.
  80. Wei Edward T. (El Cerrito CA) Kiang Juliann G. (Benicia CA), Method of inhibiting inflammatory response.
  81. Auclair Claude (Soulanges CAX), Method of using gonadorelin for the treatment of benign prostatic hyperplasia.
  82. Ivri Yehuda, Methods and apparatus for dispensing liquids as an atomized spray.
  83. Ivri Yehuda ; De Young Linda R. ; Wu Cheng H. ; Cater Miro S. ; Kumar Vijay ; Flierl Markus, Methods and apparatus for storing chemical compounds in a portable inhaler.
  84. Ivri Yehuda ; De Young Linda R. ; Wu Cheng H. ; Cater Miro S. ; Kumar Vijay ; Flierl Markus, Methods and apparatus for storing chemical compounds in a portable inhaler.
  85. Lewis, Danny; Schmidt, Paul; Hinds, Kenneth, Methods and compositions for enhanced delivery of bioactive molecules.
  86. Johnson Keith A. (Sunnyvale CA) Gordon Marc S. (Sunnyvale CA) Lyons Shirley W. (Sunnyvale CA), Methods and system for processing dispersible fine powders.
  87. Amitabh Gaur ; Paul Conlon ; Nicholas C. Ling ; Theophil Staehelin CH; Paul D. Crowe, Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein.
  88. Ekwuribe, Nnochiri N.; Price, Christopher H.; Ansari, Aslam M.; Odenbaugh, Amy L., Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties.
  89. Ekwuribe,Nnochiri N.; Price,Christopher H.; Still,James Gordon; Filbey,Jennifer Ann, Methods of treating diabetes mellitus.
  90. Ekwuribe, Nnochiri N.; Price, Christopher H.; Ansari, Aslam M.; Odenbaugh, Amy L., Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same.
  91. Ekwuribe,Nnochiri N.; Price,Christopher H.; Ansari,Aslam M.; Radhakrishnan,Balasingam; Odenbaugh,Amy L., Mixtures of insulin drug-oligomer comprising polyalkylene glycol.
  92. Ekwuribe, Nnochiri N.; Price, Christopher H.; Ansari, Aslam M.; Radhakrishnan, Balasingam; Odenbaugh, Amy L., Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same.
  93. Schmid, Roberto Rodolfo Kretschmer, Monocyte locomotion inhibitory factor.
  94. Hindle, Michael; Byron, Peter R.; Hong, John N., Mouthpiece entrainment airflow control for aerosol generators.
  95. Harris J. Milton ; Veronese Francesco Maria,ITX ; Caliceti Paolo,ITX ; Schiavon Oddone,ITX, Multiarmed, monofunctional, polymer for coupling to molecules and surfaces.
  96. Shen, Xiaoming, N-maleimidyl polymer derivatives.
  97. Shashoua Victor E. (Brookline MA), Nerve growth peptides.
  98. Joliot Alain,FRX ; Prochiantz Alain,FRX, Neurotropic growth factors comprising a homeobox peptide.
  99. Konishi Jin-emon (Musashino JPX), Peptide compounds, a process for manufacturing them, pharmaceutical compositions containing them, and methods for treati.
  100. Grau Ulrich (Hofheim am Taunus DEX), Pharmaceutical agent for the treatment of diabetes mellitus.
  101. Chance Ronald E. (Westfield IN) Frank Bruce H. (Indianapolis IN) Galloway John A. (Indianapolis IN), Pharmaceutical formulations comprising human insulin, human C-peptide, and human proinsulin.
  102. Sikiric Predrag (Jurisiceva 5 Visnjica 29 YUX) Petek Marijan (Cvjetno naselje 1/21 Visnjica 29 YUX) Rotkvic Ivo (Cvjetno naselje 1/21 41 000 Zagreb YUX) Mise Stjepan (Ruzveltova 37 58 000 Split YUX) , Pharmacologically active substance BPC, the process for its preparation and its use in the therapy.
  103. Bentley Michael D. ; Harris J. Milton, Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying amines.
  104. Harris J. Milton (Huntsville AL) Kozlowski Antoni (Huntsville AL), Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives t.
  105. J. Milton Harris ; Antoni Kozlowski, Poly(ethylene glycol) derivatives with proximal reactive groups.
  106. Richard B. Greenwald ; Yun Hwang Choe, Polymer conjugates of ara-C and ara-C derivatives.
  107. Veronese Francesco M. (Padua ITX) Schiavon Oddone (Padua ITX) Caliceti Paolo (Padua ITX) Sartore Luciana (Marano Vic. ITX) Ranucci Elisabetta (Brescia ITX) Ferruti Paolo (Milan ITX), Polymers of N-acryloylmorpholine activated at one end and conjugates with bioactive materials and surfaces.
  108. Watanabe,Takuya; Terao,Yasuko; Shintani,Yasushi, Polynucleotide encoding the hOT7T175 G protein coupled receptor.
  109. Eljamal Mohammad,LBX ; Patton John S. ; Foster Linda ; Platz Robert M., Powdered pharmaceutical formulations having improved dispersibility.
  110. Gaeta Laura S. L. ; Jones Howard ; Albrecht Elisabeth, Pramlintide pro H-amylin salts and compositions.
  111. Harris J. Milton (Huntsville AL) Sedaghat-Herati M. R. (Huntsville AL), Preparation and use of polyethylene glycol propionaldehyde.
  112. Murata, Takahiko; Ueo, Haruyoshi; Ohyama, Tadashi, Preventives or remedies for heart failure.
  113. Suenaga, Masato; Yamada, Takao; Nishimura, Osamu, Process for producing kiss-1 peptide.
  114. Gordon Marc S., Processes for spray drying aqueous suspensions of hydrophobic drugs and compositions thereof.
  115. Gordon Marc S., Processes for spray drying hydrophobic drugs in organic solvent suspensions.
  116. Gordon Marc S. ; Lord John D., Processes for spray drying solutions of hydrophobic drugs and compositions thereof.
  117. Chang, Conway C.; Gu, Chee L.; Chen, Jie; Steinberg, Deborah A.; Lehrer, Robert I.; Harwig, Sylvia S. L.; Kokryakov, Vladimir N., Protegrins.
  118. Allen Darrel LaVern ; Wolff Ronald Keith ; Leiter Paula Ann ; Tielking Richard Leon, Pulmonary and nasal delivery of raloxifene.
  119. Urdea Michael S. (Alamo CA) Horn Thomas (Berkeley CA), Purification of synthetic oligomers.
  120. Goldstein Allan Leonard (Galveston TX), Purified thymosin and process.
  121. Zimmermann Jrg (Wallbach CHX), Pyrimidine derivatives and processes for the preparation thereof.
  122. Kahn Michael, Reverse-turn mimetics and methods relating thereto.
  123. Coolidge Thomas R. (Falls Village CT) Lewis William (Lincoln NE) Schuster Sheldon M. (Gainesville FL) Wylie Dwane (Lincoln NE) Wagner Fred W. (Walton NE) Stout Jay (Lincoln NE) van Heeke Gino (Gaines, Sequential peptide and oligonucleotide syntheses using immunoaffinity techniques.
  124. Lewis William (Lincoln NE) Stout Jay (Lincoln NE) Van Heeke Gino (Lincoln NE) Wylie Dwane E. (Lincoln NE) Schuster Sheldon M. (Lincoln NE) Wagner Fred W. (Walton NE), Sequential peptide and oligonucleotide syntheses using immunoaffinity techniques.
  125. Harris, J. Milton, Soluble, degradable poly (ethylene glycol) derivatives for controllable release of bound molecules into solution.
  126. Harris, J. Milton, Soluble, degradable poly (ethylene glycol) derivatives for controllable release of bound molecules into solution.
  127. Harris J. Milton, Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution.
  128. Meisner Lorraine F. (Madison WI) Schinitsky Michael R. (Madison WI), Stabilization of proteins and peptides by chemical binding with chondroitin.
  129. Foster Linda C. ; Kuo Mei-chang ; Billingsley Shelia R., Stable glassy state powder formulations.
  130. Amstutz Gary Arthur ; Bowersox Stephen Scott ; Gohil Kishorchandra ; Adriaenssens Peter Isadore ; Kristipati Ramasharma, Stable omega conopetide formulations.
  131. Michael David Bentley ; Xuan Zhao ; Xiaoming Shen ; Lihong Guo, Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof.
  132. Ekwuribe, Nnochiri N.; Price, Christopher H.; Ansari, Aslam M.; Odenbaugh, Amy L., Substantiallymonodispersed mixtures of polymers having polyethylene glycol moieties.
  133. Wang Su-Sun (Bloomfield NJ), Synthesis of thymosin a1.
  134. Lloyd P. Johnston ; Kevin Stapleton ; Ernest Penachio, System, method and apparatus for filling containers.
  135. Levitt George (Wilmington DE), Thiophenesulfonamides.
  136. Rudolph,Alfred R.; Tuthill,Cynthia W., Thymosin alpha 1 peptide/polymer conjugates.
  137. Wei Edward T. (Berkeley CA), Treatment to reduce edema for brain and musculature injuries.
  138. Schultz Robert K. (Shoreview MN) Quessy Stephen N. (St. Paul MN), Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations.
  139. Forssmann, Wolf-Georg; Forssmann, Kristin; Greb, Wolfgang; Meyer, Markus, Use of urodilatin for treating chronic kidney failure with residual kidney functions.
  140. Fluge Thomas (Hannover DEX) Forssmann Wolf-Georg (Hannover DEX), Use of urodilatin in pulmonary and bronchial diseases.
  141. Young, Thomas M.; Young, Niels O.; Young, by Lucy J., Vaporization and pressurization of liquid in a porous material.

문의처: helpdesk@kisti.re.kr전화: 080-969-4114

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로